Scientific Sessions 2025  /  Biological and Pragmatic Interventions in Heart Failure: From Present to Future  /  Discussant: The MAPLE-HCM Trial
Logo

American Heart Association

  43
  0

Final ID:

Discussant: The MAPLE-HCM Trial

  • Day, Sharlene  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Sharlene Day: DO have relevant financial relationships ; Consultant:Lexicon Pharmaceuticals:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Consultant:Solid Biosciences:Active (exists now) ; Advisor:Cytokinetics:Active (exists now) ; Research Funding (PI or named investigator):Lexicon Pharmaceuticals:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Biological and Pragmatic Interventions in Heart Failure: From Present to Future

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
ANSWER-HF: A Randomized Controlled Trial of Sacubitril/Valsartan Versus Enalapril in Patients with Chronic Chagas Cardiomyopathy and Reduced Ejection Fraction

Madrini Junior Vagner, Antunes Talita, Damiani Lucas, Jose Grupi Cesar, Mathias Junior Wilson, Lopes Renato, Ramires Felix, Ramos Souza Paulo, Fernandes Fabio, Maria Ianni Barbara, Silva Martins Alan, JadÁn Luzuriaga Georgina Del Cisne, Cardoso Barbosa Fonseca Keila, Ribeiro Orlando, Bispo Da Cruz Allecineia

Discussant: MUSIC-HFpEF

Kawana Masataka

More abstracts from these authors:
Hypertrophic Cardiomyopathy

Day Sharlene

Molecular Regulation of Hypertrophic Signaling Pathways

Day Sharlene

You have to be authorized to contact abstract author. Please, Login
Not Available